Coronavirus News and Research

RSS

Anticardiolipin antibodies and COVID-19

A new study has shown that anticardiolipin antibodies are associated with the novel coronavirus infection or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19.

10 Jun 2020

Unique antiviral action of cholesterol 25-hydroxylase against SARS-CoV-2

A new study by U.S. and Chinese researchers, currently available on the bioRxiv* preprint server, demonstrates how cholesterol 25-hydroxylase and its enzymatic product 25-hydroxycholesterol can inhibit membrane fus

10 Jun 2020

COVID-19 pandemic impacts mental, physical health of people with obesity

The COVID-19 pandemic is having a significant impact on people with obesity as they struggle to manage their weight and mental health during shelter-in-place orders, according to research led by The University of Texas Health Science Center at Houston and UT Southwestern.

10 Jun 2020

Blood type plays role in SARS-CoV-2 infection

A new meta-analysis from Iran, available on the medRxiv preprint server, showed that the blood group A could be considered a partial risk factor for infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), whereas the blood group O may act as a protective factor; conversely, no significant associations were observed between specific blood groups and coronavirus disease (COVID-19) mortality.

10 Jun 2020

Tocilizumab in Critical COVID-19 Patients

A new study by scientists at Metro Infectious Disease Consultants and published on the preprint server medRxiv* in June 2020 reports that the cytokine blocker tocilizumab is a useful adjunct to supportive medical care in severe COVID-19, with increased survival and a lower requirement for mechanical ventilation.

10 Jun 2020

Seroprevalence of IgM and IgG against SARS-CoV-2 in China

A new study published in the journal Nature Medicine in June 2020 reports the seroprevalence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) across China. This may help to understand the actual prevalence of the virus in the current pandemic.

10 Jun 2020

Specific immune signature identified in COVID-19 patients

Researchers at King’s College London and collaborators have identified an “immune signature” that could help researchers better understand coronavirus disease 2019 (COVID-19) and serve as a valuable resource for predicting patient prognosis and informing clinical risk-based stratification.

10 Jun 2020

ASTRO's new guideline provides recommendations for radiation therapy to treat cervical cancer

A new clinical guideline from the American Society for Radiation Oncology provides recommendations for radiation therapy to treat patients with nonmetastatic cervical cancer.

10 Jun 2020

Mitigating "second wave" COVID-19 risk to health frontliners and patients

Researchers at University College London have made important discoveries about the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among frontline healthcare workers that could help to inform new policies for protecting staff and patients in the future.

10 Jun 2020

Coronavirus (COVID-19) sample tracking packages

To assist labs involved with the essential RT-PCR assay part of the “test, trace and isolate” strategy for dealing with the SARS-CoV-2 virus pandemic – Ziath has introduced two optimized packages for reliable tracking of patient samples submitted for Coronavirus (COVID-19) testing.

From Ziath Ltd 10 Jun 2020

Virologists develop new methods to inactivate and study SARS-Cov-2

Detailed methods on how to perform research on SARS-CoV-2, the virus that causes COVID-19, including procedures that effectively inactivate the virus to enable the safe study of infected cells have been identified by virologists in the Institute for Biomedical Sciences at Georgia State University.

10 Jun 2020

Role of nuclear cardiology in COVID-19

"We know that without a vaccine we're going to be dealing with this virus for a while," said Johnese Spisso, president of UCLA Health, in an interview with Johannes Czernin.

10 Jun 2020

The 1918 flu pandemic can help mitigate the spread of COVID-19

What can the 1918 flu pandemic teach people about the current COVID-19 pandemic? That's what a group of researchers at the University of Missouri hope to uncover with the help of a recent COVID-19 RAPID grant from the National Science Foundation.

10 Jun 2020

Research reveals 7 different SARS-CoV-2 strains arrived in California

The coronavirus disease (COVID-19) first emerged in Wuhan City in China in December 2019. From there, it has actively spread across the globe. The United States has been the hardest-hit country in the pandemic, with more than 1.97 million people infected.

10 Jun 2020

COVID-19 lockdowns estimated to have prevented 3 million deaths across 11 European countries

Now, a new study by researchers at Imperial College London estimates that lockdowns prevented around 3.1 million deaths in 11 European countries. The modeling study, published in the journal Nature, highlights that social distancing measures worked in reducing the spread of the virus.

10 Jun 2020

Researchers examine the drying time of virus' droplets on various surfaces

One of the many questions researchers have about COVID-19 is how long the coronavirus causing the disease remains alive after someone infected with it coughs or sneezes.

10 Jun 2020

Deep UV LED inactivation of SARS-CoV-2 - fast and effective

The ongoing pandemic has aroused considerable effort to find methods to prevent and control the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19 disease. Rapid inactivation devices would be of great help in this area, to prevent viral transmission through aerosols and contact with infected surfaces.

9 Jun 2020

Lockdowns combined with widespread use of facemasks can stop the resurgence of SARS-CoV-2

Population-wide use of facemasks keeps the coronavirus 'reproduction number' under 1.0, and prevents further waves of the virus when combined with lockdowns, a modelling study from the universities of Cambridge and Greenwich suggests.

9 Jun 2020

Unique mutations could weaken Indian SARS-CoV-2 strain

A new study published on the preprint server bioRxiv in June 2020 suggests that the presence of unique mutations in the viral strains circulating in India has led to their attenuation.

9 Jun 2020

A drug to treat harsh complications of coronavirus infection is registered in Russia

Levilimab received state approval through a fast-track mechanism, according to Decree No. 441 of the Government of the Russian Federation of April 4, 2020, since its mechanism of action is associated with the control of the cytokine storm, which is one of the manifestations of coronavirus infection.

9 Jun 2020